- Home
- Publications
- Publication Search
- Publication Details
Title
Trailblazing perspectives on targeting breast cancer stem cells
Authors
Keywords
Breast cancer, Cancer stem cell, PD-1/PD-L1, Transcription factor, Epithelial-mesenchymal transition, Tumor microenvironment, CAF, Non-coding RNAs
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 223, Issue -, Pages 107800
Publisher
Elsevier BV
Online
2021-01-08
DOI
10.1016/j.pharmthera.2021.107800
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA Approval Summary: Atezolizumab plus paclitaxel protein-bound for the treatment of patients with advanced or metastatic TNBC whose tumors express PD-L1
- (2020) Preeti Narayan et al. CLINICAL CANCER RESEARCH
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Isolation and characterization of breast cancer stem cell‐like phenotype by Oct4 promoter‐mediated activity
- (2020) Zahra Ghanei et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis
- (2020) Jianying Pei et al. Journal of Translational Medicine
- Methylation Status of the Nanog Promoter Determines the Switch between Cancer Cells and Cancer Stem Cells
- (2020) Shupeng Liu et al. Advanced Science
- PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
- (2020) Fatmah A. Mansour et al. OncoImmunology
- Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
- (2020) Kirti S. Prabhu et al. Cancers
- Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
- (2020) Olga E. Savelieva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Re-definition of claudin-low as a breast cancer phenotype
- (2020) Christian Fougner et al. Nature Communications
- Response of Breast Cancer Cells to PARP Inhibitors Is Independent of BRCA Status
- (2020) Man Yee Keung et al. Journal of Clinical Medicine
- PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?
- (2020) Anthony Gonçalves et al. Cancers
- The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
- (2020) Justin M Brown et al. Cells
- Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
- (2020) Dayanidhi Raman et al. Frontiers in Oncology
- Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β
- (2020) Vanessa Bellat et al. BMC CANCER
- The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker
- (2020) Behrad Darvishi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
- (2020) Anwesha Dey et al. NATURE REVIEWS DRUG DISCOVERY
- Not all fibroblasts are equal in cancer
- (2020) Ioannis Zervantonakis Science Translational Medicine
- SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR
- (2020) Lina Zhao et al. Advanced Science
- Regulating stem cell-related genes induces the plastic differentiation of cancer stem cells to treat breast cancer
- (2020) Jing-Ying Zhang et al. Molecular Therapy-Oncolytics
- Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1
- (2020) Liqin Xia et al. BMC CANCER
- Pembrolizumab in the preoperative setting of triple-negative breast cancer: safety and efficacy
- (2020) Romualdo Barroso-Sousa et al. Expert Review of Anticancer Therapy
- miR‑376c‑3p modulates the properties of breast cancer stem cells by targeting RAB2A
- (2020) Feng Zhao et al. Experimental and Therapeutic Medicine
- Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells
- (2020) Phuoc Vinh Nguyen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p
- (2020) Saurabh Mandal et al. LIFE SCIENCES
- The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway
- (2020) Su-Lim Kim et al. MOLECULES
- ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells
- (2020) Peter Cruz-Gordillo et al. Science Signaling
- MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
- (2020) Simona Ruxandra Volovat et al. Frontiers in Oncology
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
- (2019) Pramod Darvin et al. Journal of Oncology
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
- (2019) Lorenzo Castagnoli et al. ONCOGENE
- Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells
- (2019) Fengfei Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
- (2019) Valerio Ciccone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- β1 Integrin is Essential for Fascin‐Mediated Breast Cancer Stem Cell Function and Disease Progression
- (2019) Rayanah Barnawi et al. INTERNATIONAL JOURNAL OF CANCER
- CD44 splice isoform switching determines breast cancer stem cell state
- (2019) Honghong Zhang et al. GENES & DEVELOPMENT
- Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis
- (2019) Liang Guo et al. CANCER LETTERS
- Therapeutics strategies against cancer stem cell in breast cancer
- (2019) Faezeh Ghasemi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer
- (2019) Lewei Zhu et al. Cancer Management and Research
- Cancer prognosis: Considering tumor and its microenvironment as a whole
- (2019) Dan Qi et al. EBioMedicine
- ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells
- (2019) Dejan Vidovic et al. CELL DEATH AND DIFFERENTIATION
- Microenvironmental regulation of long non-coding RNA LINC01133 promotes cancer-stem-cell-like phenotypic traits in triple-negative breast cancers
- (2019) Zhenbo Tu et al. STEM CELLS
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- A genome‐wide RNA i screen reveals essential therapeutic targets of breast cancer stem cells
- (2019) Abir Arfaoui et al. EMBO Molecular Medicine
- The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells
- (2019) Yuan Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- CD133 in Breast Cancer Cells: More than a Stem Cell Marker
- (2019) Federica Brugnoli et al. Journal of Oncology
- Radiation and Stemness Phenotype May Influence Individual Breast Cancer Outcomes: The Crucial Role of MMPs and Microenvironment
- (2019) María Auxiliadora Olivares-Urbano et al. Cancers
- Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells
- (2019) Alfredo García-Venzor et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
- (2019) Chun-Hui Lee et al. BMC CANCER
- Lipid Droplets Define a Sub-Population of Breast Cancer Stem Cells
- (2019) Benjamin J. Hershey et al. Journal of Clinical Medicine
- Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker
- (2018) Christopher J O'Conor et al. Biomarkers in Medicine
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction
- (2018) Feiyu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Meeting the needs of breast cancer: A nucleolin’s perspective
- (2018) Ana C. Gregório et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling
- (2018) Xinhua Xie et al. CURRENT CANCER DRUG TARGETS
- Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges
- (2018) Gurpreet Kaur et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Correction to: Emerging role of lipid metabolism alterations in Cancer stem cells
- (2018) Mei Yi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Emerging role of lipid metabolism alterations in Cancer stem cells
- (2018) Mei Yi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
- (2018) Bernard Asselain et al. LANCET ONCOLOGY
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2018) Wenzhe Li et al. Scientific Reports
- Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling
- (2018) Justin A. Colacino et al. Stem Cell Reports
- High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
- (2018) In-geun Ryoo et al. Redox Biology
- The First National Institutes of Health Institutional Training Program in Emergency Care Research: Productivity and Outcomes
- (2018) Craig D. Newgard et al. ANNALS OF EMERGENCY MEDICINE
- SOX9/FXYD3/Src axis is critical for ER+ breast cancer stem cell function
- (2018) Yue Xue et al. MOLECULAR CANCER RESEARCH
- Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor
- (2018) Deli Hong et al. MOLECULAR CANCER RESEARCH
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- VEGF–neuropilin-2 signaling promotes stem-like traits in breast cancer cells by TAZ-mediated repression of the Rac GAP β2-chimaerin
- (2018) Ameer L. Elaimy et al. Science Signaling
- Breast cancer stem cells: Features, key drivers and treatment options
- (2018) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
- (2018) Yuanyuan Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
- (2018) Valerio Ciccone et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
- (2018) Xia Liu et al. Cancer Discovery
- Breast cancer stem cells: Biology and therapeutic implications
- (2018) Ramesh Butti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
- (2017) Sheema Almozyan et al. INTERNATIONAL JOURNAL OF CANCER
- HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells
- (2017) Mansi Shah et al. Molecular Cancer
- Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies
- (2017) Komal Qureshi-Baig et al. Molecular Cancer
- CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
- (2017) Yong Wha Moon et al. Oncotarget
- Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells
- (2017) Ningning Yan et al. Oncotarget
- PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 Expression
- (2017) Kelly Chiang et al. Cell Reports
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype
- (2017) W. A. da Silveira et al. Scientific Reports
- A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment
- (2017) Neha Nair et al. Scientific Reports
- Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2017) Wenzhe Li et al. Scientific Reports
- Understanding EGFR Signaling in Breast Cancer and Breast Cancer Stem Cells: Overexpression and Therapeutic Implications
- (2016) Ibrahim O Alanazi et al. Asian Pacific Journal of Cancer Prevention
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
- (2016) Athanasia Pavlopoulou et al. CANCER LETTERS
- Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
- (2016) D. Peng et al. CANCER RESEARCH
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Hippo pathway and breast cancer stem cells
- (2016) Marcello Maugeri-Saccà et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation
- (2016) Ivan Bahena‐Ocampo et al. EMBO REPORTS
- miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation
- (2016) Ivan Bahena‐Ocampo et al. EMBO REPORTS
- Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide
- (2016) Su-Hyeong Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting aberrant expression of Notch-1 in ALDH+cancer stem cells in breast cancer
- (2016) Deeksha Pal et al. MOLECULAR CARCINOGENESIS
- Targeting metastasis-initiating cells through the fatty acid receptor CD36
- (2016) Gloria Pascual et al. NATURE
- Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy
- (2016) Prasad R. Dandawate et al. SEMINARS IN CANCER BIOLOGY
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis
- (2016) Madison Black et al. Oncotarget
- A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy
- (2016) Chiara D’Avino et al. Oncotarget
- Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination
- (2015) Nuno A. Fonseca et al. BIOMATERIALS
- Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters
- (2015) So-Young Chun et al. BIOMEDICINE & PHARMACOTHERAPY
- Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium
- (2015) Zhong-Ming Feng et al. BMC CANCER
- The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate
- (2015) Su-Hyeong Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- Noncoding RNAs in breast cancer
- (2015) Pang-Kuo Lo et al. Briefings in Functional Genomics
- Epigenetic Activation of TWIST1 by MTDH Promotes Cancer Stem-like Cell Traits in Breast Cancer
- (2015) Y. Liang et al. CANCER RESEARCH
- Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement
- (2015) Hani Goodarzi et al. CELL
- Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
- (2015) Hyangsoon Noh et al. Cell Communication and Signaling
- Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer
- (2015) Michael D. Brooks et al. Cell Stem Cell
- Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling
- (2015) Ying Lu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
- (2015) Mauricio Rodriguez-Torres et al. CLINICAL & EXPERIMENTAL METASTASIS
- Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer
- (2015) Chun Hu et al. JOURNAL OF DRUG TARGETING
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
- (2015) Xin Ye et al. NATURE
- Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
- (2015) Devon A. Lawson et al. NATURE
- Human anti-nucleolin recombinant immunoagent for cancer therapy
- (2015) Dario Palmieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Cancer Stem Cells: The Promise and the Potential
- (2015) Jaffer A. Ajani et al. SEMINARS IN ONCOLOGY
- Abnormal expression of the Notch and Wnt/β-catenin signaling pathways in stem-like ALDHhiCD44+ cells correlates highly with Ki-67 expression in breast cancer
- (2015) JUNWEI CUI et al. Oncology Letters
- Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells
- (2015) Hyunsook An et al. PLoS One
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
- (2014) Z. Gatalica et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Suppressive expression of CD274 increases tumorigenesis and cancer stem cell phenotypes in cholangiocarcinoma
- (2014) Keiichi Tamai et al. CANCER SCIENCE
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer
- (2014) T R Sarkar et al. ONCOGENE
- VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
- (2014) D Zhao et al. ONCOGENE
- Role of the protein C receptor in cancer progression
- (2014) Wolfram Ruf et al. THROMBOSIS RESEARCH
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Molecular and Cellular Heterogeneity in Breast Cancer
- (2013) Ashley G. Rivenbark et al. AMERICAN JOURNAL OF PATHOLOGY
- Hyaluronic Acid-Based Nanogel–Drug Conjugates with Enhanced Anticancer Activity Designed for the Targeting of CD44-Positive and Drug-Resistant Tumors
- (2013) Xin Wei et al. BIOCONJUGATE CHEMISTRY
- Quantification of residual risk of relapse in breast cancer patients optimally treated
- (2013) Maria Vittoria Dieci et al. BREAST
- FOXC2 Expression Links Epithelial-Mesenchymal Transition and Stem Cell Properties in Breast Cancer
- (2013) B. G. Hollier et al. CANCER RESEARCH
- CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression
- (2013) Yunshan Wang et al. CANCER RESEARCH
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway
- (2013) L. McClements et al. CLINICAL CANCER RESEARCH
- Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
- (2013) K.-D. Yu et al. CLINICAL CANCER RESEARCH
- Salinomycin: A Novel Anti-Cancer Agent with Known Anti-Coccidial Activities
- (2013) Shuang Zhou et al. CURRENT MEDICINAL CHEMISTRY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- The Natural Inhibitor of DNA Topoisomerase I, Camptothecin, Modulates HIF-1 Activity by Changing miR Expression Patterns in Human Cancer Cells
- (2013) D. Bertozzi et al. MOLECULAR CANCER THERAPEUTICS
- The shaping and functional consequences of the microRNA landscape in breast cancer
- (2013) Heidi Dvinge et al. NATURE
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer
- (2013) Q Li et al. ONCOGENE
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Breast cancer, side population cells and ABCG2 expression
- (2012) K.M. Britton et al. CANCER LETTERS
- EMT in breast cancer stem cell generation
- (2012) Stéphane Ansieau CANCER LETTERS
- Control of Breast Cancer Growth and Initiation by the Stem Cell-Associated Transcription Factor TCF3
- (2012) M. Slyper et al. CANCER RESEARCH
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
- (2012) Virginia Tirino et al. FASEB JOURNAL
- Breast Cancer Stem Cells, Pathways and Therapeutic Perspectives 2011
- (2012) Anjana Nigam Indian Journal of Surgery
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of microRNAs in the Regulation of Breast Cancer Stem Cells
- (2012) Suling Liu et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice
- (2012) Anne-Pierre Morel et al. PLoS Genetics
- Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications
- (2011) Julia Izrailit et al. CANCER LETTERS
- TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype
- (2011) M. K. Asiedu et al. CANCER RESEARCH
- Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
- (2011) Suling Liu et al. CANCER RESEARCH
- Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative
- (2011) A. Biddle et al. CANCER RESEARCH
- Nucleolin Maintains Embryonic Stem Cell Self-renewal by Suppression of p53 Protein-dependent Pathway
- (2011) Acong Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insight into the heterogeneity of breast cancer through next-generation sequencing
- (2011) Hege G. Russnes et al. JOURNAL OF CLINICAL INVESTIGATION
- EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Donggen Liu et al. MEDICAL ONCOLOGY
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling
- (2011) P-K Lo et al. ONCOGENE
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
- (2011) F Yu et al. ONCOGENE
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triple-Negative Breast Cancer
- (2010) Anthony D. Elias AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells
- (2010) Dominik Fuchs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
- (2010) Poornima Bhat-Nakshatri et al. BMC CANCER
- Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue
- (2010) Sibyll Hein et al. BREAST CANCER RESEARCH AND TREATMENT
- Overall survival and PD-L1 expression in metastasized malignant melanoma
- (2010) Jules Gadiot et al. CANCER
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Treatment of triple negative breast cancer (TNBC): current options and future perspectives
- (2010) M. De Laurentiis et al. CANCER TREATMENT REVIEWS
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
- (2010) Roberta Pang et al. Cell Stem Cell
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Breast cancer stem cells: initiating a new sort of thinking
- (2010) J. I. Herschkowitz Disease Models & Mechanisms
- TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype
- (2010) Gianluca Storci et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Embryonic Transcription Cofactor LBH Is a Direct Target of the Wnt Signaling Pathway in Epithelial Development and in Aggressive Basal Subtype Breast Cancers
- (2010) M. E. Rieger et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting breast cancer stem cells
- (2010) Sean P. McDermott et al. Molecular Oncology
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells
- (2009) Dominik Fuchs et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel therapeutic approaches to the treatment of metastatic breast cancer
- (2009) Yolanda Fernández et al. CANCER TREATMENT REVIEWS
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- The Notch signaling pathway: Transcriptional regulation at Notch target genes
- (2009) T. Borggrefe et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers
- (2009) Wendy W. Hwang-Verslues et al. PLoS One
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
- (2008) E Spaeth et al. GENE THERAPY
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search